<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmj</journal-id><journal-title-group><journal-title xml:lang="ru">Тихоокеанский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Pacific Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1609-1175</issn><publisher><publisher-name>TGMU</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/PmJ1609-1175.2018.4.89-90</article-id><article-id custom-type="elpub" pub-id-type="custom">pmj-292</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PUBLIC HEALTH ORGANIZATION</subject></subj-group></article-categories><title-group><article-title>Серологический мониторинг при оценке эффективности вакцинопрофилактики пневмококковой инфекции у детей в организованных коллективах</article-title><trans-title-group xml:lang="en"><trans-title>Serological monitoring by evaluation of the effectiveness of vaccine prophylaxis of pneumococcal infection in organized groups of children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесник</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnik</surname><given-names>D. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гончаров</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Goncharov</surname><given-names>A. E.</given-names></name></name-alternatives><email xlink:type="simple">phage1@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колоджиева</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolodzhieva</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нилова</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Nilova</surname><given-names>L. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нечаев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Netchaev</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Оришак</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orishak</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Северо-Западный государственный медицинский университет им. И.И. Мечникова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>North-West State Medical University named after I.I. Mechnikov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Северо-Западный государственный медицинский университет им. И.И. Мечникова; Институт экспериментальной медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>North-West State Medical University named after I.I. Mechnikov; Institute ofExperimental Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2018</year></pub-date><volume>0</volume><issue>4</issue><fpage>89</fpage><lpage>90</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колесник Д.С., Гончаров А.Е., Колоджиева В.В., Нилова Л.Ю., Нечаев В.В., Оришак Е.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Колесник Д.С., Гончаров А.Е., Колоджиева В.В., Нилова Л.Ю., Нечаев В.В., Оришак Е.А.</copyright-holder><copyright-holder xml:lang="en">Kolesnik D.S., Goncharov A.E., Kolodzhieva V.V., Nilova L.Y., Netchaev V.V., Orishak E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.tmj-vgmu.ru/jour/article/view/292">https://www.tmj-vgmu.ru/jour/article/view/292</self-uri><abstract><p>Оценена серотиповая структура популяции Streptoccoccus pneumoniae на фоне внедрения массовой вакцинопрофилактики пневмококковой инфекции. Показано снижение распространенности серотипов возбудителя под действием 13-валентной конъюгированной пневмококковой вакцины среди носителей в детских коллективах по сравнению с показателем, полученным в той же группе населения в довакцинальный период. Очевидна необходимость в продолжении серологического мониторинга как элемента оценки эффективности вакцинации.</p></abstract><trans-abstract xml:lang="en"><p>Objective. The study objective is to establish the epidemiological features of Streptococcus pneumoniae carrier of different serotypes in organized children groups during vaccinal prevention. Methods. 1574 children were examined on the nasal S. pneumoniae carriage aged 2-7 y.o., having gone to preschool institutions of St. Petersburg. Results. The percentage of S. Pneumoniae serotype strains covered by the action of 13-valent vaccine, was 36.03 %, that is lower than corresponding value (65.4 %), determined in a similar design study in St. Petersburg in 2010-2013. At the same time, it remained unclear whether this reduction could be considered the result of vaccine prevention, since the level of coverage with preventive vaccinations in the studied population was then quite low. Conclusions. The wide spread of pneumococcal serotypes, unreached by the action of the 13-valent pneumococcal vaccine, on the one hand, indicates the need for constant monitoring of the pathogen population during mass immunization programs, and on the other hand, it makes it possible to raise the question of the need to expand the antigenic repertoire of the vaccines used.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вакцинопрофилактика</kwd><kwd>серологический мониторинг</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Streptoccoccus pneumoniae</kwd><kwd>Streptococcus pneumoniae</kwd><kwd>vaccine prophylaxis</kwd><kwd>serological monitoring</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Брико Н.И., Лобзин Ю.В., Баранов А.А. [и др.]. Оценка эффективности вакцинации: основные подходы и спорные вопросы // Педиатрическая фармакология. 2014. Т. 11, № 4. С. 8-15</mixed-citation><mixed-citation xml:lang="en">Брико Н.И., Лобзин Ю.В., Баранов А.А. [и др.]. Оценка эффективности вакцинации: основные подходы и спорные вопросы // Педиатрическая фармакология. 2014. Т. 11, № 4. С. 8-15</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Перова А.Л., Рудакова А.В., Харит С.М. Эффективность конъюгированной пневмококковой вакцины для профилактики пневмококковых инфекций // Журнал инфектологии. 2014. Т. 6, № 2. С. 43-47</mixed-citation><mixed-citation xml:lang="en">Перова А.Л., Рудакова А.В., Харит С.М. Эффективность конъюгированной пневмококковой вакцины для профилактики пневмококковых инфекций // Журнал инфектологии. 2014. Т. 6, № 2. С. 43-47</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Федосеенко М.В., Новикова Д.А., Ткаченко Н.Е. [и др.[. Опыт применения и оценка безопасности 13-валентной пневмококковой конъюгированной вакцины у детей младше 5 лет // Педиатрическая фармакология. 2014. Т. 11, № 5. С. 59-64</mixed-citation><mixed-citation xml:lang="en">Федосеенко М.В., Новикова Д.А., Ткаченко Н.Е. [и др.[. Опыт применения и оценка безопасности 13-валентной пневмококковой конъюгированной вакцины у детей младше 5 лет // Педиатрическая фармакология. 2014. Т. 11, № 5. С. 59-64</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Daniels C.C., Rogers P.D., Shelton C.M. A review of pneumococcal vaccines: Current polysaccharide vaccine recommendations and future protein antigens // J. Pediatr. Pharmacol. Ther. 2016. Vol. 21, No. 1. P. 27-35.</mixed-citation><mixed-citation xml:lang="en">Daniels C.C., Rogers P.D., Shelton C.M. A review of pneumococcal vaccines: Current polysaccharide vaccine recommendations and future protein antigens // J. Pediatr. Pharmacol. Ther. 2016. Vol. 21, No. 1. P. 27-35.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children // Lancet. 2001. Vol. 357, No. 9260. P. 950-951.</mixed-citation><mixed-citation xml:lang="en">Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children // Lancet. 2001. Vol. 357, No. 9260. P. 950-951.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Nukka A., Ahman H., Yaich M. [et al.]. Serum and salivary antiantibodies in infants and children immunized with heptavalent pneumococcal conjugate vaccine // Pediatric Infectious Diseases Journal. 2001. Vol. 20. P 25-33.</mixed-citation><mixed-citation xml:lang="en">Nukka A., Ahman H., Yaich M. [et al.]. Serum and salivary antiantibodies in infants and children immunized with heptavalent pneumococcal conjugate vaccine // Pediatric Infectious Diseases Journal. 2001. Vol. 20. P 25-33.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pimenta F.C., Gertz Jr. R.E., Roundtree A. [et al.]. Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations // J. Clin. Microbiol. 2009. Vol. 47, No. 7. P. 2353-2354.</mixed-citation><mixed-citation xml:lang="en">Pimenta F.C., Gertz Jr. R.E., Roundtree A. [et al.]. Rarely occurring 19A-like cps locus from a serotype 19F pneumococcal isolate indicates continued need of serology-based quality control for PCR-based serotype determinations // J. Clin. Microbiol. 2009. Vol. 47, No. 7. P. 2353-2354.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X., Theodore M.J., Mair R. [et al.]. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens // J. Clin. Microbiol. 2012. Vol. 50, No. 3. P. 702-708.</mixed-citation><mixed-citation xml:lang="en">Wang X., Theodore M.J., Mair R. [et al.]. Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens // J. Clin. Microbiol. 2012. Vol. 50, No. 3. P. 702-708.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
